GO
Loading...

FDA To Delay Galvus?

Tuesday, 20 Feb 2007 | 5:05 AM ET

Market sources tell CNBC Europe that the FDA may deal a blow to Novartis at the end of the month when it publishes findings on Galvus, Novartis' blockbuster pipeline diabetes drug. CNBC's Dan Scott reports from Zurich.